This market has seen a flurry of activity, as shown by a review of the latest agents.
Although the pandemic halted many medical mission assignments, these opportunities and others are becoming available to help those geographic areas with acute needs.
For patients undergoing surgery, looking at the potential benefits of this antimicrobial for prophylaxis.
Epidemiologic and clinical lessons for the uninitiated.
Will there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?
Extending antimicrobial stewardship programs to transition of care and discharge may prove beneficial to reduce unnecessary antibiotic use.
Tina Tan, MD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Priya Nori, MD; Jacinda Abdul-Mutakabbir, PharmD; and Kevin Michael Reiter, MD, PA, provide key takeaways from the discussion on the treatment of respiratory viral infections.
In a collaboration between the University of Oxford, the Ministry of Health in Rwanda, and the Rwanda Biomedical Centre, groundbreaking data on the R21/Matrix-M malaria vaccine, marks a significant shift in the malaria paradigm.
A review of the data and circumstances that led to authorization in children ages 5 to 11 years.
Conflicting priorities of infection control, antimicrobial stewardship, and critical care make the management of sepsis secondary to SARS-CoV-2 infection challenging.
Conflicting priorities of infection control, antimicrobial stewardship, and critical care make the management of sepsis secondary to SARS-CoV-2 infection challenging.
This bipartisan initiative highlights the need for a comprehensive approach to combat antimicrobial resistance (AMR), incorporating both antibiotic drug development and increased funding for stewardship programs.
Traditional therapy coverage does not include recent data that offers some updates in evaluating the current effectiveness of empiric antibiotic treatment.
How pharmacists can use shared decision-making to improve antibiotic use.
Experts provide practice pearls for educating patients on and using FMTs for the management of CDI.
Will there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?
Four lessons learned from the AIDS crisis that can be applied to the fight against our current pandemic.
In the latest article from SIDP, here is a look at therapy options addressing this emerging clinical challenge.
The challenging search for a metric that effectively evaluates an ASP’s direct impact on appropriate antimicrobial use and improved patient outcomes.
Will this winter bring the feared twindemic of SARS-CoV-2 and influenza, or will another common infection reemerge?
There is value in leveraging the contributions of nurses, laboratorians, and informaticists in antimicrobial stewardship.
Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.
Similar to HIV, the colonial and postcolonial history is fundamental to the biology of this monkeypox outbreak.
Implications for antimicrobial use and antimicrobial resistance.
Here is a look at some of the treatment alternatives, which can offer simpler logistics and cost considerations.
Two RSV vaccines for seniors were FDA approved this year and here is an overview of the vaccines and the study data.
Vaccination for VZV and HPV requires special consideration in immunocompromised patients. They are at risk for more severe viral illnesses if not immune, but they may also have decreased response to, and increased adverse effects from, vaccines.
This agent is likely best utilized as part of a combination when treating this bacterium but data regarding appropriate combinations are scarce.